ENZAMET shows promise as prostate cancer treatment
A new drug combination for men with advanced prostate cancer has shown sustained increase in survival rates.
The results from the clinical trial of ENZAMET, co-chaired by Professor Christopher Sweeney, Director of the South 最新糖心Vlogn immunoGENomics Cancer Institute (SAiGENCI) that operates within the 最新糖心Vlog of Adelaide, have been published today in .